ESC 2021: Late-breaking Science Video Collection

Published: 02 September 2021

  • Views:

    Views Icon 1678
  • Likes:

    Heart Icon 2

Overview

Full programme

  • Views:

    Views Icon 1678
  • Likes:

    Heart Icon 2

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data. 

For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

Series overview

Part 1

View from the Thoraxcenter

In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the hot line and late-breaking trials that will be presented at ESC Congress 2021. What presentations should we look at for this weekend? Get your update on the importance of trials such as GUIDE-HF, MASTER DAPT, TOMAHAWK and many more delivered by our world-class experts, Professor Van Mieghem and Dr Joost Daemen.

2 sessions

  • View from the Thoraxcenter – What's Hot at ESC 2021

    Watch now
  • View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

    Watch now

Part 2

Late-breaker Discussion Series

Host, Dr Harriette Van Spall interviews the late-breaker and hot line presenters of ESC Congress 2021.

3 sessions

  • ESC 2021 Discussion: The EMPEROR-Preserved Trial

    Watch now
  • ESC 2021 Discussion: The FIGARO-DKD Trial

    Watch now
  • ESC 2021 Discussion: The EMPEROR-Pooled Study

    Watch now

Part 3

Expert Interviews

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

11 sessions

  • ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

    Watch now
  • SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI

    Watch now
  • TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

    Watch now
  • The LAAOS III Study: Surgical AFIB Ablation Evaluation

    Watch now
  • TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

    Watch now
  • STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS

    Watch now
  • SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

    Watch now
  • RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

    Watch now
  • VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes

    Watch now
  • Micra CED: 2-Year Outcomes with Leadless Pacing

    Watch now
  • RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

    Watch now

Part 4

Masterclass with Dr Harriette Van Spall & Dr Birgit Vogel

In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.

1 session

  • Masterclass on The Global Burden of CV Disease in Women

    Watch now

Faculty biographies